Steven R. Smith, MD, AdventHealth’s chief scientific officer discussed AdventHealth Translational Research Institute’s decade of discovery in Central Florida on a recent webinar with the Florida Medical Association. “I’ve never been more optimistic about the state of biomedical science and medical science than I am right now,” Smith said.
Smith, who has overseen TRI since its inception, explained the medical research currently taking place, and where the Translational Research Institute (TRI), is headed. “We feel an obligation to conduct research. We want to learn from our patients so we can improve the care we provide them,” Smith said.
TRI’s mission is to extend and improve the quality of lives by conducting world-class, innovative translational research that leads to discoveries and ultimately cures for obesity, diabetes and cardiovascular diseases. Over the past 10 years, TRI researchers have conducted more than 200 studies and produced more than 350 peer reviewed, published works that have helped to advance medicine. Smith explained, “To define it simply, translation is bedside to bench. We’re going to study human biology with cells, tissue and DNA and then we’re going to relate that back to the human condition.”
During the conversation, Smith spoke about the importance of collaboration and innovation in research and answered questions from viewers.
You can watch the webinar by clicking play below:
Before the webinar, FMA invited Smith to talk about why TRI is unique, its milestones and what excited him most about the work being done there. Click here to read that article.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
News
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism and co-authored by Dr. Corbin introduces a metagenomics-powered approach to...
News
Mayor Demings, AdventHealth on bridging health care gaps
Discover what’s being accomplished in Central Florida to bridge the health gap with Orange County Mayor Jerry Demings and AdventHealth’s Dr. Alric Simmonds.
News
Transforming lives of stroke survivors: AdventHealth, Orlando Neurosurgery first in nation to perform 50 Vivistim implant cases
Breakthrough device offers new hope for stroke survivors struggling with rehabilitation following ischemic stroke
News
AdventHealth Inflammatory Bowel Disease Clinic Adds Intestinal Ultrasound to Help Evaluate and Guide Treatment
Jennifer Seminerio, MD, recently became one of the first in Florida to use intestinal ultrasound (IUS) to help assess and manage treatment of patients with inflammatory bowel disease (IBD). A non...
News
AdventHealth Daytona Beach Surgeon First in Florida to Perform Robotic-assisted Convergent Hybrid Ablation Procedure
The Convergent Hybrid Ablation procedure has been gaining acceptance as an effective treatment option for long-standing persistent atrial fibrillation (AFib) since the CONVERGE trial data published in...
News
Pediatric Orthopedic Surgery Team Reaches Milestone with Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR®) Implant and Advances Surgical Approach
Recently, AdventHealth for Children pediatric orthopedic surgeon Sean Keyes, DO, Katelyn Smith, PA-C, and their team performed their 100th bridge-enhanced anterior cruciate ligament (ACL) repair (BEAR...
News
Respiratory Virus Testing Guidance for Flu Season
Physician leaders from AdventHealth’s emergency department, infectious disease, inpatient, pediatrics and pharmacy teams all collaborated to develop a respiratory virus testing algorithm to assist...
News
AdventHealth Celebration Introduces New Intraoperative Molecular Imaging Process to Improve Accuracy of Lung Cancer Surgery
Thoracic surgeon Colleen Gaughan, MD, and her team at AdventHealth Celebration, recently became one of the first in the country to incorporate targeted imaging agent Cytalux (pafolacianine) as part of...
News
An incredible journey through two open heart surgeries at AdventHealth
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
News
Using Genomics and AI to Improve Breast Cancer Risk Assessment and Early Detection
AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program that combines the use of digital mammography, artificial intelligence (AI) technology...
News
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma
AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...